Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Cameco
CCJ
$42.4B
| $3.77M | ﹤0.01% |
424,072
-148,657
| -26% | -$1.37M |
|
2302
Franklin Electric
FELE
$4.84B
| $3.77M | ﹤0.01% |
65,772
+18,194
| +38% | +$961K |
|
2303
The GEO Group
GEO
$4.04B
| $3.77M | ﹤0.01% |
226,860
+37,457
| +20% | +$569K |
|
|
XLRN
2304
DELISTED
Acceleron Pharma
XLRN
| $3.77M | ﹤0.01% |
71,076
-21,470
| -23% | -$979K |
|
2305
CALL
iShares Core S&P Small-Cap ETF
IJR
$112B
| $3.77M | ﹤0.01% |
44,900
+12,100
| +37% | +$974K |
|
|
JOBS
2306
DELISTED
51job Inc
JOBS
| $3.76M | ﹤0.01% |
44,301
+17,969
| +68% | +$1.44M |
|
|
FMBI
2307
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $3.76M | ﹤0.01% |
162,944
+55,458
| +52% | +$1.18M |
|
2308
CALL
Colgate-Palmolive
CL
$74.4B
| $3.75M | ﹤0.01% |
54,500
-145,400
| -73% | -$9.91M |
|
2309
PUT
Deckers Outdoor
DECK
$13.3B
| $3.75M | ﹤0.01% |
133,200
-12,000
| -8% | -$318K |
|
|
FLAT
2310
DELISTED
iPath US Treasury Flattener ETN
FLAT
| $3.74M | ﹤0.01% |
54,000
| – | – |
|
2311
Bausch Health
BHC
$2.34B
| $3.74M | ﹤0.01% |
125,125
-120,406
| -49% | -$3.13M |
|
|
GSS
2312
DELISTED
Golden Star Resources Ltd.
GSS
| $3.74M | ﹤0.01% |
+981,927
| New | +$3.14M |
|
2313
Axos Financial
AX
$5.68B
| $3.74M | ﹤0.01% |
123,461
+32,045
| +35% | +$936K |
|
2314
CALL
Quest Diagnostics
DGX
$26.3B
| $3.74M | ﹤0.01% |
35,000
-1,000
| -3% | -$104K |
|
|
UCB
2315
United Community Banks
UCB
$4.28B
| $3.73M | ﹤0.01% |
120,973
+43,202
| +56% | +$1.31M |
|
|
JJM
2316
DELISTED
iPath Series B Bloomberg Industrial Metals Subindex Total ReturnSM ETN
JJM
| $3.73M | ﹤0.01% |
85,000
| – | – |
|
2317
Natural Resource Partners
NRP
$1.42B
| $3.72M | ﹤0.01% |
185,000
| – | – |
|
2318
LG Display
LPL
$3.3B
| $3.72M | ﹤0.01% |
535,650
-4,400
| -0.8% | -$27.4K |
|
2319
IAMGOLD
IAG
$10.5B
| $3.72M | ﹤0.01% |
996,139
+976,557
| +4,987% | +$3.45M |
|
|
JJE
2320
DELISTED
iPath Series B Bloomberg Energy Subindex Total ReturnSM ETN
JJE
| $3.71M | ﹤0.01% |
80,000
| – | – |
|
2321
United Parks & Resorts
PRKS
$2.12B
| $3.71M | ﹤0.01% |
117,013
-31,702
| -21% | -$914K |
|
2322
Semtech
SMTC
$13B
| $3.71M | ﹤0.01% |
70,070
+37,280
| +114% | +$1.87M |
|
2323
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $3.7M | ﹤0.01% |
63,500
-131,000
| -67% | -$7.26M |
|
2324
Northwest Natural Holdings
NWN
$2.12B
| $3.68M | ﹤0.01% |
49,900
+2,826
| +6% | +$195K |
|
2325
Canadian Solar
CSIQ
$1.08B
| $3.68M | ﹤0.01% |
166,352
+81,222
| +95% | +$1.47M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.